Table 4 Odds ratios of clinical predictors of cirrhosis outcome in the NAFLD-associated HCC cohort.

From: Improved survival after treatments of patients with nonalcoholic fatty liver disease associated hepatocellular carcinoma

 

Unadjusted

P value

Adjusted

P value

Sex

1.97

0.170

Age*

0.286

BMI*

<0.001

1.162

0.010

Not Hispanic ethnicity

0.075

<0.001

0.091

0.003

T2D

1.59

0.478

1.464

0.515

Dyslipidemia

0.321

0.027

0.538

0.306

  1. *Age and BMI analysis conducted in quartiles with student t-test for statistical testing. BMI = body mass index; T2D = type 2 diabetes.
  2. #Model adjusted for ethnicity, dyslipidemia, T2D and BMI (per unit).